AI assistant
Biocon Ltd. — Regulatory Filings 2020
Nov 11, 2020
61176_rns_2020-11-11_39e18d77-7eff-427a-abfc-b6c1f401e087.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
==> picture [88 x 35] intentionally omitted <==
Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA1978PLC003417
Date of submission: November 11, 2020
To To The Secretary The Secretary BSE Limited National Stock Exchange of India Limited Department of Corporate Services Corporate Communication Department Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai – 400 001 Mumbai – 400 050 Scrip Code - 532523 Scrip Symbol- BIOCON
Dear Sir/Madam,
Sub: Meetings conducted with Institutional Investors/Research Analysts.
Ref: Intimation under Regulation 30 (6) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.
Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, we hereby inform you that the following meetings were conducted with Institutional Investor / Research Analysts:
| Date | Name | Type of meeting | Location |
|---|---|---|---|
| November 10,2020 | Aberdeen Standard Investments | Teleconference | Bangalore |
| Aegon Life Insurance | |||
| Aikya Investment Management | |||
| AlquityInvestment Management Ltd | |||
| India First Life Insurance | |||
| November 11, 2020 | Malabar InvestmentsMulti-Act EquityConsultancy | 1x1 & GroupMeetings viateleconference | Bangalore |
| One UpFinancial Consultants | |||
| Padma India Fund | |||
| PNB Metlife Insurance | |||
| Quest Investment Advisors |
We request you to kindly take above intimation on record.
Thanking You,
Yours faithfully,
For Biocon Limited
==> picture [76 x 33] intentionally omitted <==
==> picture [70 x 74] intentionally omitted <==
Mayank Verma
Company Secretary and Compliance Officer